Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,164 | -3,380 |
| Depreciation Amortization | 37 | 150 |
| Accounts receivable | -4 | N/A |
| Accounts payable and accrued liabilities | 134 | N/A |
| Other Working Capital | 359 | -60 |
| Other Operating Activity | 32 | -120 |
| Operating Cash Flow | $-607 | $-3,410 |
| Cash Flows From Investing Activities | ||
| PPE Investments | 164 | 490 |
| Other Investing Activity | -76 | -860 |
| Investing Cash Flow | $88 | $-370 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 228 | N/A |
| Debt Repayment | -65 | N/A |
| Other Financing Activity | 316 | 2,260 |
| Financing Cash Flow | $479 | $2,260 |
| Beginning Cash Position | 57 | 1,580 |
| End Cash Position | 16 | 50 |
| Net Cash Flow | $-40 | $-1,520 |
| Free Cash Flow | ||
| Operating Cash Flow | -607 | -3,410 |
| Capital Expenditure | -2 | N/A |
| Free Cash Flow | -610 | -3,410 |